Costa Allysson, Brito Gleisson A P
Laboratory of Physiology and Developmental Biology, Federal University of Latin American Integration-UNILA, Foz do Iguaçu, Paraná, Brazil.
J Nutr Metab. 2019 Sep 9;2019:4586963. doi: 10.1155/2019/4586963. eCollection 2019.
This review compiled anthropometric data from 29 original articles, published between 1995 and 2015, corresponding to a total sample of 6368 celiac disease subjects. Body mass index was the main parameter for measuring anthropometry (82.1%), followed by body mass (78.6%), body fat (51.7%), bone mineral density and bone mineral content (46.4%), and fat-free mass (44.8%). The main evaluation method was dual x-ray absorptiometry (83.3%), followed by bioimpedance (16.6%), skinfold thickness (16.6%), and isotope dilution (5.5%). This compilation suggests that celiac disease patients without a gluten-free diet (WGFD) and celiac disease patients with a gluten-free diet (GFD) show a lower body mass than the control group, with inconclusive data about WGFD versus GFD. Body mass index is lower in WGFD and GFD compared to control group, and is lower in WGFD compared to GFD. We observed lower values of FM and FFM in WGFD and GFD versus the control group. No difference was found between WGFD versus GFD. BMD and BMC are lower in WGFD versus GFD and GFD versus the control group, with inconclusive data about WGFD versus GFD. The findings of this review suggest that celiac disease patients must be periodically evaluated through anthropometric parameters, since the pathology has the potential to modulate such values even in a gluten-free diet, with these variables reflecting their healthy status. In parallel, the screening of different anthropometric assessment methodologies can provide support for more accurate evaluations by scientists and clinical professionals who work with celiac disease patients.
本综述汇总了1995年至2015年间发表的29篇原始文章中的人体测量数据,这些数据对应6368例乳糜泻患者的总样本。体重指数是测量人体测量学的主要参数(82.1%),其次是体重(78.6%)、体脂(51.7%)、骨矿物质密度和骨矿物质含量(46.4%)以及去脂体重(44.8%)。主要评估方法是双能X线吸收法(83.3%),其次是生物电阻抗法(16.6%)、皮褶厚度法(16.6%)和同位素稀释法(5.5%)。这一汇总表明,未采用无麸质饮食(WGFD)的乳糜泻患者和采用无麸质饮食(GFD)的乳糜泻患者的体重均低于对照组,关于WGFD与GFD的数据尚无定论。与对照组相比,WGFD和GFD患者的体重指数较低,且WGFD患者的体重指数低于GFD患者。我们观察到,与对照组相比,WGFD和GFD患者的脂肪量(FM)和去脂体重(FFM)值较低。WGFD与GFD之间未发现差异。与GFD组和对照组相比,WGFD组的骨密度(BMD)和骨矿物质含量(BMC)较低,关于WGFD与GFD的数据尚无定论。本综述的结果表明,乳糜泻患者必须通过人体测量参数进行定期评估,因为即使在无麸质饮食情况下,该疾病仍有可能调节这些数值,这些变量反映了他们的健康状况。同时,对不同人体测量评估方法的筛选可为从事乳糜泻患者工作的科学家和临床专业人员进行更准确的评估提供支持。